Clinical trial · Observational
CRC Post-surgical Assessment and Recurrence Monitoring
Colorectal Cancer Post-surgical Therapeutic Effect Assessment and Recurrence Monitoring by Methylated SEPT9
NCT03334890CI-TRIAL-00030243unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The surgical therapeutic effect of stage II-IV CRC patients will be assessed by the plasma mSEPT9 assay, and patients will be followed up by the same assay for recurrence monitoring.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| plasma mSEPT9 level | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- mSEPT9 level
- timeFrame
- Jan 1, 2016 to Dec 31, 2017
- description
- the Ct values representing the mSEPT9 level in plasma
Secondary outcomes (3)
- measure
- CEA level
- timeFrame
- Jan 1, 2016 to Dec 31, 2017
- description
- the serum CEA level
- measure
- tumor size
- timeFrame
- Jan 1, 2016 to Dec 31, 2017
- description
- the maximal diameter of tumor measured with CT images
- measure
- CR,PR,SD,PD
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * stage II-IV CRC patients planning to perform surgery Exclusion Criteria: * stage 0-I CRC patients, patients with history of CRC or other cancers, patients not suitable for surgery, pregnant women, patients younger than 30 or older than 80.
References
Publications (0)
Data not yet available
No reference posted for this study.